Pro Creation D

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Ingrédients actifs:

Morinda officinalis, Quantity: 45 mg (Equivalent: Morinda officinalis, Qty 270 mg); Rehmannia glutinosa, Quantity: 45 mg (Equivalent: Rehmannia glutinosa, Qty 270 mg); Angelica polymorpha, Quantity: 35 mg (Equivalent: Angelica polymorpha, Qty 210 mg); Schisandra chinensis, Quantity: 25 mg (Equivalent: Schisandra chinensis, Qty 150 mg); Paeonia lactiflora, Quantity: 30 mg (Equivalent: Paeonia lactiflora, Qty 180 mg); Astragalus membranaceus, Quantity: 60 mg (Equivalent: Astragalus membranaceus, Qty 360 mg); Rubus chingii, Quantity: 25 mg (Equivalent: Rubus chingii, Qty 150 mg); Alpinia oxyphylla, Quantity: 30 mg (Equivalent: Alpinia oxyphylla, Qty 180 mg); Cuscuta hygrophilae, Quantity: 50 mg (Equivalent: Cuscuta hygrophilae, Qty 300 mg); Dioscorea oppositifolia, Quantity: 30 mg (Equivalent: Dioscorea oppositifolia, Qty 180 mg); Cynomorium Coccineum subsp. Songaricum, Quantity: 50 mg (Equivalent: Cynomorium Coccineum subsp. Songaricum, Qty 300 mg); Astragalus complanatus, Quantity: 30 mg (Equivalent: Astragalus complanatus, Qty 180 mg); Cullen corylifolium, Quantity: 45 mg (Equivalent: Cullen corylifolium, Qty 270 mg)

Disponible depuis:

BlueSkyGreenEarth Herbs Pty Ltd

DCI (Dénomination commune internationale):

Alpinia oxyphylla,Angelica polymorpha,Astragalus complanatus,Astragalus membranaceus,Cullen corylifolium,Cuscuta hygrophilae,Cyn

forme pharmaceutique:

Capsule, hard

Composition:

Excipient Ingredients: titanium dioxide; Gelatin

Mode d'administration:

Oral

classe:

Medicine Listed

indications thérapeutiques:

Maintain/support immune system health ; Support healthy stress response in the body

Descriptif du produit:

Visual Identification: ;

Statut de autorisation:

Licence status A

Date de l'autorisation:

2004-04-01